FDA has announced it has expanded the approved use of Humira (adalimumab), manufactured by Abbott Laboratories, to include treatment of moderate-to-severe ulcerative colitis in adults, according to a ...

Thanks to the safety scrutiny on the JAK inhibitor class of drugs, AbbVie’s optimism for its Humira follow-on Rinvoq might have shifted from unbridled to cautious. But in the meantime, the versatile ...

Medically reviewed by Mary Choy, PharmD Key Takeaways Biologic medications help reduce inflammation in ulcerative colitis. If you're new to biologics, infliximab might be your first option for ...

Humira is a blockbuster rheumatoid arthritis drug that can now be used for adults with hard to treat ulcerative colitis. The FDA just approved the use by adults to help control the chronic condition ...

- ENTYVIO ® superior to Humira ® in achieving clinical remission and mucosal healing at week 52 in patients with moderately to severely active ulcerative colitis OAKVILLE, ON, March 11, 2019 /CNW/ - ...

Sept 28 (Reuters) - U.S health regulators on Friday approved Abbott Laboratories Inc's blockbuster rheumatoid arthritis drug Humira for the treatment of moderate to severe ulcerative colitis in adults ...

The FDA recently designated Yuflyma as "interchangeable" with the popular biologic Humira for the treatment of Crohn's disease and ulcerative colitis, two types of inflammatory bowel disease (IBD), ...

WASHINGTON, Aug 24 (Reuters) - Abbott Laboratories Inc may need to conduct additional trials of Humira to prove the blockbuster drug helps patients with ulcerative colitis, U.S. drug reviewers said on ...

Does CRC Risk in IBD Extend to Close Family Members? Close relatives of people with IBD are not at increased risk for CRC, strengthening the theory that it's the inflammation or atypia of the colon ...

Biologics in IBD: More Thoughtful Use Could Improve Outcomes The marketplace introduction of infliximab for the treatment of IBD did not reduce hospitalization or surgery rates in a large population ...